Kinfo
Pfizer Inc. logo

Pfizer Inc.

PFENYSEHealthcare·US · USD
$27.41
-0.39 (-1.40%)
Prices as of October 5, 2026 · market closed

Price

Key statistics

Valuation
Market cap156.23B USD
Enterprise value210.53B USD
Trailing P/E36.58
Forward P/E9.60
PEG ratio-0.34
Price / sales2.49
Price / book1.86
Profitability
Gross margin72.78%
Operating margin27.88%
Profit margin6.80%
Return on assets5.78%
Return on equity5.01%
Income (TTM)
Revenue63.70B USD
Gross profit47.59B USD
EBITDA25.49B USD
Net income4.34B USD
Diluted EPS$0.76
Rev. growth (YoY)2.60%
Balance sheet
Total cash11.70B USD
Total debt63.48B USD
Debt / equity74.25
Current ratio1.27
Book value / share$14.95
Cash flow (TTM)
Operating cash flow13.40B USD
Levered free cash flow12.49B USD
Shares & price
Shares outstanding5.70B
Float5.69B
Held by institutions69.10%
Beta0.30
50-day MA$27.33
200-day MA$26.40
52-week high$29.21
52-week low$23.62
Dividends
Forward rate
$1.72
Yield
6.28%
Payout ratio
226.32%
Frequency
Quarterly
Recent payments
  • 2026-07-24$0.43
Earnings (EPS)
DateEst.ActualSurprise2026-08-040.680.77+13.24%2026-07-233.323.52+6.02%2026-05-050.720.75+4.17%2026-02-030.570.66+15.79%2025-11-040.630.87+38.10%
About Pfizer Inc.

Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines for people worldwide. Its current portfolio spans oncology, vaccines, internal medicine, inflammation and immunology, rare diseases, and hospital-based care, supported by a broad commercial network that serves physicians, hospitals, pharmacies, governments, and healthcare systems. Pfizer also maintains a consumer health presence through established over-the-counter and wellness products in select markets. The company plays a central role in global healthcare by supplying prescription therapies and immunizations across major therapeutic areas, while its research and development organization continues to support the launch, approval, and lifecycle management of new treatments. Founded in 1849 and headquartered in New York City, Pfizer Inc. remains one of the most recognized names in the pharmaceutical industry.

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dr. Albert Bourla D.V.M., Ph.D.
Employees
75,000
Headquarters
New York, NY, United States

Frequently asked questions about Pfizer Inc.